XML 52 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
Derivative Liabilities
3 Months Ended
Feb. 28, 2014
Notes to Financial Statements  
Derivative Liabilities

Note 10.       Derivative Liabilities

 

The Company evaluated their convertible note agreements pursuant to ASC 815 and due to there being no minimum or fixed conversion price resulting in an indeterminate number of shares to be issued in the future, the Company determined an embedded derivative existed and ASC 815 applied for their convertible notes. The Company valued the embedded derivatives using the Black-Scholes valuation model.  

  

Convertible debt with a variable conversion feature

 

In 2014, we estimated the fair value of the derivatives using the Black-Scholes valuation method with assumptions including: (1) term of 0 to 1.25 years; (2) a computed volatility rate of 201% (3) a discount rate of 1% and (4) zero dividends.  Upon settlement the valuation of this embedded derivative was recorded as gain/loss on derivative liability.

 

In 2013, we estimated the fair value of the derivatives using the Black-Scholes valuation method with assumptions including: (1) term of 0.7 to 3 years; (2) a computed volatility rate of 229 to 283% (3) a discount rate of 0.13 to 0.25% and (4) zero dividends.  Upon settlement the valuation of this embedded derivative was recorded as gain/loss on derivative liability.

 

Tainted conventional convertible debt

 

In 2014, we estimated the fair value of the derivative using the Black-Scholes valuation method with assumptions including: (1) term of 0 to 1.75 years; (2) a computed volatility rate of 201% (3) a discount rate of 1% and (4) zero dividends.  The valuation of this embedded derivative was recorded with an offsetting gain/loss on derivative liability.

 

In 2013, we estimated the fair value of the derivative using the Black-Scholes valuation method with assumptions including: (1) term of 0 to 1.0 years; (2) a computed volatility rate of 232 to 243% (3) a discount rate of 1% and (4) zero dividends.  The valuation of this embedded derivative was recorded with an offsetting gain/loss on derivative liability.

 

Tainted stock options and warrants

 

The Company also evaluated all outstanding warrants and options to determine whether these instruments may be tainted. All warrants outstanding were considered tainted as a result of the tainted equity environment and potential inability of the Company to settle the instruments with shares of the Company’s stock as the number of shares issuable cannot be estimated and could exceed that amount of authorized shares available to be issued by the Company. The Company valued the embedded derivatives within the stock options and warrants using the Black-Scholes valuation model.  

 

In 2014, we estimated the fair value of the derivative using the Black-Scholes valuation method with assumptions including: (1) term of 0 to 8.25 years; (2) a computed volatility rate of 201% (3) a discount rate of 1% and (4) zero dividends.  The valuation of this embedded derivative was recorded with an offsetting gain/loss on derivative liability.

 

In 2013, we estimated the fair value of the derivative using the Black-Scholes valuation method with assumptions including: (1) term of 1.0 to 7.5 years; (2) a computed volatility rate of 232% (3) a discount rate of 1% and (4) zero dividends.  The valuation of this embedded derivative was recorded with an offsetting gain/loss on derivative liability.

 

Activity for embedded derivative instruments during the three months ended February 28, 2014 was as follows:

 

      Initial valuation            
      of derivative            
      liabilities upon  Change in   Exercise      
   Balance at  issuance of new  fair value of  of stock  Conversion  Balance at
   November 30,  securities during  derivative  options/  of debt   February 28,
   2013  the period  liabilities  warrants  to equity  2014
Variable convertible debt  $1,467,182   $230,837   $(117,289)  $—     $(300,920)  $1,279,810 
Tainted convertible debt   139,953    —      (121,361)   —      —      18,592 
Tainted stock options   30,343    —      (20,898)   —      —      9,445 
Tainted warrants   34,866    —      (25,929         —      8,937 
   $1,672,344   $230,837   $(285,477)  $—     $(300,920)  $1,316,784 

 

 

Activity for embedded derivative instruments during the three months ended February 28, 2013 was as follows:

 

      Initial valuation            
      of derivative            
      liabilities upon  Change in   Exercise      
   Balance at  issuance of new  fair value of  of stock  Conversion  Balance at
   November 30,  securities during  derivative  options/  of debt   February 28,
   2012  the period  liabilities  warrants  to equity  2013
Variable convertible debt  $361,760   $1,946,880   $2,269,698   $—     $(308,797)  $4,269,541 
Tainted convertible debt   264,189         1,071,965    —      (286)   1,335,868 
Tainted stock options   49,483         12,012    —      —      61,500 
Tainted warrants   27,973         82,444    —      —      110,417 
   $703,405   $1,946,880   $3,436,119   $—     $(309,083)  $5,777,326